RxDoctor Payments Data

Carlee Young

Optometrist · Frisco, TXNPI 1457732562

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 94.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $16,047 and has fallen 98.8% since, to $189 in 2025. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,929in general payments, 2019–2025

Across 76 payments — averaging $328.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$24K
  • Alcon$557
  • Biotissue Holdings Inc.$205
  • Johnson & Johnson Vision Care, Inc.$168
  • Bausch & Lomb Americas Inc.$158
  • AbbVie$104
  • plus $136 from 5 others
$16,970in research payments, 2019–2025

Across 4 payments — averaging $4242.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coopervision Inc.$17K

What the payments were for

  • Consulting fees$11,95048%
  • Speaking & faculty fees$9,25037%
  • Travel & lodging$1,0974%
  • Food & beverage$2,63211%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,929 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.

See all optometrist providers in Texas

Medicare billing

Part B allowed, 2024
$1,779
Medicare patients
11
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →